Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Clinical studies of patients with bladder cancers].
Nakagawa Y, Matsuda T, Kawamura H, Murota T, Ohara T, Komatsu Y. Nakagawa Y, et al. Among authors: komatsu y. Hinyokika Kiyo. 1992 Apr;38(4):389-94. Hinyokika Kiyo. 1992. PMID: 1529810 Free article. Japanese.
[Complications in urological laparoscopic surgery].
Matsuda T, Uchida J, Muguruma K, Mikami O, Komatsu Y, Terachi T, Horii Y, Ogura K, Arai Y, Takeuchi H, et al. Matsuda T, et al. Among authors: komatsu y. Hinyokika Kiyo. 1993 Apr;39(4):337-43. Hinyokika Kiyo. 1993. PMID: 8503330 Free article. Japanese.
Effects of medicinal plants on hemopoietic cells.
Ikehara S, Kawamura H, Komatsu Y, Yamada H, Hisha H, Yasumizu R, Ohnishi-Inoue Y, Kiyohara H, Hirano M, Aburada M, et al. Ikehara S, et al. Among authors: komatsu y. Adv Exp Med Biol. 1992;319:319-30. doi: 10.1007/978-1-4615-3434-1_32. Adv Exp Med Biol. 1992. PMID: 1414601
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients.
Shitara K, Yamanaka T, Denda T, Tsuji Y, Shinozaki K, Komatsu Y, Kobayashi Y, Furuse J, Okuda H, Asayama M, Akiyoshi K, Kagawa Y, Kato T, Oki E, Ando T, Hagiwara Y, Ohashi Y, Yoshino T. Shitara K, et al. Among authors: komatsu y. Ann Oncol. 2019 Feb 1;30(2):259-265. doi: 10.1093/annonc/mdy526. Ann Oncol. 2019. PMID: 30508156 Free article. Clinical Trial.
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer.
Iida N, Imai M, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Ebi H, Taniguchi H, Nonomura N, Sunakawa Y, Shiozawa M, Yamazaki K, Boku S, Bando H, Shiraishi Y, Kobayashi M, Goto H, Sato A, Fujii S, Yoshino T, Nakamura Y. Iida N, et al. Among authors: komatsu y. Clin Cancer Res. 2024 Sep 13;30(18):4167-4178. doi: 10.1158/1078-0432.CCR-24-1023. Clin Cancer Res. 2024. PMID: 39163021 Free PMC article.
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer.
Jogo T, Nakamura Y, Shitara K, Bando H, Yasui H, Esaki T, Terazawa T, Satoh T, Shinozaki E, Nishina T, Sunakawa Y, Komatsu Y, Hara H, Oki E, Matsuhashi N, Ohta T, Kato T, Ohtsubo K, Kawakami T, Okano N, Yamamoto Y, Yamada T, Tsuji A, Odegaard JI, Taniguchi H, Doi T, Fujii S, Yoshino T. Jogo T, et al. Among authors: komatsu y. Clin Cancer Res. 2021 Oct 15;27(20):5619-5627. doi: 10.1158/1078-0432.CCR-21-1414. Epub 2021 Aug 10. Clin Cancer Res. 2021. PMID: 34376535 Free PMC article.
1,601 results